Michael Barras

2.3k total citations
96 papers, 1.5k citations indexed

About

Michael Barras is a scholar working on Geriatrics and Gerontology, Cardiology and Cardiovascular Medicine and Emergency Medical Services. According to data from OpenAlex, Michael Barras has authored 96 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Geriatrics and Gerontology, 26 papers in Cardiology and Cardiovascular Medicine and 22 papers in Emergency Medical Services. Recurrent topics in Michael Barras's work include Pharmaceutical Practices and Patient Outcomes (43 papers), Patient Safety and Medication Errors (20 papers) and Venous Thromboembolism Diagnosis and Management (20 papers). Michael Barras is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (43 papers), Patient Safety and Medication Errors (20 papers) and Venous Thromboembolism Diagnosis and Management (20 papers). Michael Barras collaborates with scholars based in Australia, Hong Kong and New Zealand. Michael Barras's co-authors include Jennifer Martin, Neil Cottrell, Nazanin Falconer, Julian Lindsay, Ian Scott, Alison Kearney, Michael Fay, Bruce Green, Centaine L. Snoswell and Alison Mudge and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Michael Barras

86 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Barras Australia 20 541 325 215 189 178 96 1.5k
Charles E. Leonard United States 26 268 0.5× 516 1.6× 191 0.9× 156 0.8× 163 0.9× 127 2.3k
Ida Fortino Italy 24 337 0.6× 450 1.4× 280 1.3× 135 0.7× 187 1.1× 108 1.9k
Peter J. Zed Canada 29 733 1.4× 366 1.1× 148 0.7× 116 0.6× 462 2.6× 108 2.5k
Sherrie L. Aspinall United States 22 618 1.1× 212 0.7× 285 1.3× 119 0.6× 138 0.8× 63 1.4k
Lyne Lalonde Canada 27 675 1.2× 580 1.8× 498 2.3× 135 0.7× 179 1.0× 69 2.0k
Marc Afilalo Canada 25 383 0.7× 282 0.9× 492 2.3× 149 0.8× 184 1.0× 80 2.6k
Peter Loewen Canada 20 368 0.7× 381 1.2× 174 0.8× 40 0.2× 179 1.0× 86 1.5k
Mary G. Amato United States 23 797 1.5× 424 1.3× 283 1.3× 51 0.3× 172 1.0× 57 2.0k
Martina Teichert Netherlands 19 235 0.4× 272 0.8× 148 0.7× 82 0.4× 124 0.7× 81 1.1k
Jean M. Nappi United States 20 306 0.6× 477 1.5× 75 0.3× 185 1.0× 147 0.8× 83 1.5k

Countries citing papers authored by Michael Barras

Since Specialization
Citations

This map shows the geographic impact of Michael Barras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Barras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Barras more than expected).

Fields of papers citing papers by Michael Barras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Barras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Barras. The network helps show where Michael Barras may publish in the future.

Co-authorship network of co-authors of Michael Barras

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Barras. A scholar is included among the top collaborators of Michael Barras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Barras. Michael Barras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barras, Michael, et al.. (2025). Impact evaluation of the modified adverse inpatient medication event (AIME-Frail) model in hospitalised adults. Research in Social and Administrative Pharmacy. 21(9). 687–696.
2.
Barras, Michael, et al.. (2024). Prevention of venous thromboembolism after total hip and knee arthroplasties in Australian hospitals: what are we using?. Journal of Pharmacy Practice and Research. 54(4). 287–295.
3.
4.
Yerkovich, Stephanie T., et al.. (2024). Measuring the impact of pharmaceutical care bundle delivery on patient outcomes: an observational study. International Journal of Clinical Pharmacy. 46(5). 1172–1180. 4 indexed citations
5.
Scott, Ian, et al.. (2022). Predicting Therapeutic Response to Unfractionated Heparin Therapy: Machine Learning Approach. SHILAP Revista de lepidopterología. 11(2). e34533–e34533. 9 indexed citations
6.
Gurunathan, Usha, Michael Barras, Catherine McDougall, Harshal Nandurkar, & Victoria Eley. (2022). Obesity and the Risk of Venous Thromboembolism after Major Lower Limb Orthopaedic Surgery: A Literature Review. Thrombosis and Haemostasis. 122(12). 1969–1979. 12 indexed citations
7.
Donovan, Peter, et al.. (2020). A randomised trial of pharmacist-led discharge prescribing in an Australian geriatric evaluation and management service. International Journal of Clinical Pharmacy. 43(4). 847–857. 5 indexed citations
8.
Barras, Michael, et al.. (2020). A Narrative Review of Aspirin Resistance in VTE Prophylaxis for Orthopaedic Surgery. Drugs. 80(18). 1889–1899. 9 indexed citations
9.
George, Christopher H., Michael Barras, Judith Coombes, & Karl Winckel. (2020). Unfractionated heparin dosing in obese patients. International Journal of Clinical Pharmacy. 42(2). 462–473. 7 indexed citations
10.
Snoswell, Centaine L., et al.. (2020). Transit Care Hub pharmacist: improving patient flow within the hospital. International Journal of Clinical Pharmacy. 42(5). 1319–1325. 3 indexed citations
11.
Barras, Michael, et al.. (2020). Economic benefits of pharmacy technicians practicing at advanced scope: A systematic review. Research in Social and Administrative Pharmacy. 16(10). 1344–1353. 16 indexed citations
12.
Mudge, Alison, et al.. (2019). Systematic review of interventions to improve safety and quality of anticoagulant prescribing for therapeutic indications for hospital inpatients. European Journal of Clinical Pharmacology. 75(12). 1645–1657. 8 indexed citations
13.
Falconer, Nazanin, Michael Barras, & Neil Cottrell. (2018). Systematic review of predictive risk models for adverse drug events in hospitalized patients. British Journal of Clinical Pharmacology. 84(5). 846–864. 51 indexed citations
14.
Hennig, Stefanie, et al.. (2018). Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?. Clinical Pharmacokinetics. 58(3). 389–399. 19 indexed citations
15.
Falconer, Nazanin, Michael Barras, Jennifer Martin, & Neil Cottrell. (2018). Defining and classifying terminology for medication harm: a call for consensus. European Journal of Clinical Pharmacology. 75(2). 137–145. 36 indexed citations
16.
Barras, Michael, et al.. (2017). Drug dosing in obese adults. Australian Prescriber. 40(5). 189–193. 82 indexed citations
17.
Barras, Michael, et al.. (2015). Compliance With Enoxaparin Dosing and Monitoring Guidelines and the Impact on Patient Length of Stay. Therapeutic Drug Monitoring. 38(1). 59–63. 3 indexed citations
18.
Norris, Ross, Jennifer Martin, John E. Ray, et al.. (2010). Current Status of Therapeutic Drug Monitoring in Australia and New Zealand: A Need for Improved Assay Evaluation, Best Practice Guidelines, and Professional Development. Therapeutic Drug Monitoring. 32(5). 615–623. 31 indexed citations
19.
Barras, Michael, Carl M. J. Kirkpatrick, & Bruce Green. (2010). Current dosing of low‐molecular‐weight heparins does not reflect licensed product labels: an international survey. British Journal of Clinical Pharmacology. 69(5). 520–528. 17 indexed citations
20.
Barras, Michael. (2002). Abnormal Laboratory Results. Journal of Pharmacy Practice and Research. 32(2). 159–159. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles E. Leonard Breakdown of academic impact, for papers by Ida Fortino Breakdown of academic impact, for papers by Peter J. Zed Breakdown of academic impact, for papers by Sherrie L. Aspinall Breakdown of academic impact, for papers by Lyne Lalonde Breakdown of academic impact, for papers by Marc Afilalo Breakdown of academic impact, for papers by Peter Loewen Breakdown of academic impact, for papers by Mary G. Amato Breakdown of academic impact, for papers by Martina Teichert Breakdown of academic impact, for papers by Jean M. Nappi
Rankless by CCL
2026